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Psychophysiological Investigations of Myocardial
Ischemia (PIMI): Initial Results on Mechanisms of
Cardiac Ischemia
The Survival Advantage of Early Grade 3 Patency
After Thrombolysis for Infarction Increases Over
Time
ACUTE MYOCARDIAL INFARCTION/UNSTABLE ANGINA-
LONG-TERM OUTCOME
The survival advantage for thrombolytic treated infarct patients who exhibit
prompt (90') full coronary patency, grade 3, (versus incomplete, 2, or absent
flow, 0,1) is well established at time points of one week or one month. The
GUSTO angiographic study now allows inspection of subsequent changes,
if any, in the flow grade specific patency-mortality relationships to one full
year's follow up. Of 1173 patients in whom infarct artery (IRA) patency grade
was established angiographically 90' after treatment was begun, 12 month
follow up is available in 99.9% (1172). Patency-1 year mortality relationships
were:
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shock assisted with the intraaortic balloon pump.
In conclusion, IV Am administration is highly effective in restoring sinus
rhythm in AF complicating AMI and is well tolerated.
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Psychological factors are linked to outcomes in coronary artery disease
(CAD) pts but the mechanisms are obscure. The PIMI is a NIH multicenter
study designed to test the overall hypothesis that manifestations and ex-
pressions of ischemia are influenced by specific psycho-physiologic mecha-
nisms. Accordingly, 200 pts, mean age 62, with CAD and ischemia responses
on treadmill were studied. Ambulatory ECG (AECG) monitoring, psychologi-
cal instrument batteries and plasma biochemical tests were applied to iden-
tify mechanisms associated with ischemia during daily life, exercise and
mental stress without influence of cardiac medications. Daily life ischemia
(AECGI occurred in 41% of pts (95% with ischemia were asymptomatic)
and was associated with lower hostility (p < 0.01) and anger expression
(p < 0.03) scores compared with those without daily life ischemia. An in-
verse association between magnitude of daily life ischemia and these scores
was observed. No differences were found for depression (Beck) or anxiety
scores. On treadmill all pts had ischemia (ST segment depression) but 44%
had angina. Angina expression was associated with higher depression (p =
0.002), anxiety (State, p = 0.002 and Trait. p = 0.01) and autonomic percep-
tion (p ~ 0.05) scores than no angina. Depression best predicted time to
angina (Cox model. p ~ 0.007).
During mental stress (Stroop and speech tasks) ischemia (radionuclide
ventriculogram (RVG) or ST segment abnormalities) occurred in 79% of pts
(95% with ischemia were asymptomatic) and associated with higher Re-
ward, Dependence, (Temperament and Character Inventory, p < 0.02) and
level of irritation during Stroop task (p < 0.01). Plasma norepinephrine re-
mained low, but epinephrine doubled and systolic pressure increased. No
associations were found for medical or demographic factors examined. Dur-
ing bicycle exercise ischemia (RVG abnormality) occurred in 94% of pts (64%
with ischemia were asymptomatic) yet norepinephrine increased three-fold.
In summary, daily life ischemia (usually asymptomatic) is associated with
suppressed hostility, anger and emotion but not depression or anxiety. Men-
tal stress ischemia (mostly asymptomatic and with epinephrine release) is re-
lated to temperament characteristics. Exercise stress ischemia, on the other
hand, more often evokes symptoms and marked norepinephrine release but
symptom expression seems dependent upon depression, anxiety and auto-
nomic perception. Mechanisms responsible for ischemia evoked in different
settings and its symptomatic expression involve complex interactions of be-
havioral, physiological and psychophysiological factors.
Genetic Predisposition to Neurohumoral
Activation Following Myocardial Infarction: Effects
of the Angiotensin Converting Enzyme I/O
Polymorphism
ABSTRAcrS
death-n (%) CHF(%) ischemia (%) v. fib(%) pacing (%) shock (%)
gr. A 504(31) 14.3 22.1 5.4 60 33
gr. B 214(30) 10.7 18.9 4.7 4.0 22
P NS P< 0.01 P < 001 NS P < 001 P < 001
Intravenous Amiodarone Restores Sinus Rhythm
in Acute Myocardial Infarction Complicated with
Atrial Fibrillation
Recent studies suggest that a deletion polymorphism of the angiotensin
converting enzyme (ACE) gene is associated with increased plasma ACE
activity and an increased risk for both, myocardial infarction (MI) and left
ventricular hypertrophy (LVH). To test the hypothesis whether the deletion
ACE genotype also affects neurohumoral activation following MI. we stud-
ied 96 patients, 59 ± 9 years of age, with acute anterior MI, no overt heart
failure, or need for ACE-inhibition. Subjects were randomized to treatment
with either captopril or placebo following thrombolytic therapy. Bloodsam-
pies for plasma norepinephrine and ACE activity were taken at baseline (be-
fore thrombolysis) and 1, 12 and 24 hours after thrombolysis. ACE genotyp-
ing (polymerase chain reaction; specific primers amplifying 190 bp and 490
bp fragments of deletion [0] and insertion [I] alleles, respectively) was car-
ried out at the end of follow-up, without knowledge of clinical parameters.
At baseline, norepinephrine levels were equal in DO, I/O and II groups. In
contrast, the increase of norepinephrine levels was more pronounced in MI
patients with DO (n = 34; 556 ± 189 pg/ml) as compared to 10 and II geno-
type (n = 62; 96 ± 98 pg/ml; p < 0.01). Furthermore, baseline ACE activity
was higher in the DO genotype group (29 ± 3 vs 23 ± 2 U/I; p = 0.01) This
increased response in DO genotype patients was blunted by captopril. As-
sociation of the DO genotype and adverse neurohumoral activation was still
evident after correction for infarct size and captopril treatment (p < 0.01)
Thus, the ACE/DO genotype appears to increase the risk for neurohumoral
activation after anterior MI and DO genotype patients benefit most from early
ACE inhibition.
The effectiveness and tolerance of intravenous (IV) amiodarone (Am) in atrial
fibrillation (AF) complicated acute myocardial infarction (AMI) is not well stud-
ied. Thus, twenty patients !pts) with AMI complicated with AF occurring
within 30 h (11.9 ± 10) of the onset of AMI symptoms were treated with
IV administration of digitalis (d, 0.5 mg and an additional 025 mg later) fol-
lowed by IV Am 300 mg over 2 h (starting 2 h after the initial dose of d) and
followed by 44 mg/h for up to 3 days, if sinus rhythm (SR) was not restored.
Intravenous d restored SR within 2 h in 5/20 pts. AF relapsed in 2 of them.
Subsequent administration of Am for 2 h restored SR in the remaining 15/20
pts and in the 2 pts in whom AF had relapsed after the initial restoration of
SR by d. Am restored SR within an average of 12.8 (range 0.5-56) h of infu-
sion. Total dose of Am was 1922 ± 720 mg in 4 pts and 425 ± 241 mg in the
remaining 13. Am was well tolerated by all pts including 1 with cardiogenic
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the group receiving it only orally within the first 24 hours (gr.B. n = 6732).
GUSTO tested four regimens of thrombolysis: accelerated t-PA with IV hep-
arin, streptokinase (SK) with IV/subcutaneous heparin and combination of
t-PA and SK with IV heparin, in 41,021 patients. Atenolol was administered,
if not contraindicated, as two doses of 5 mg. IV. every 15 minutes followed by
50-100 mg. orally every day. In 9987 patients, there were contra indications
to its use, as perceived by the enrolling physician. The baseline character-
istics of the patients receiving IV atenolol were not unfavorable in terms of
previous infarction, Killip class, assignment to t-PA, age, systolic pressure,
heart rate or time to treatment, when compared with the whole cohort re-
ceiving atenolol within the first 24 hours. The main events are listed below:
(CHF - congestive heart failure, v.fib - ventricular fibrillation):
There was a similar incidence of reinfarction and angiographic reocclusion
in the 2 groups. Although not a randomized comparison, the utilization of IV
atenoloI in the first 24 hours after myocardial infarction, was paradoxically
associated with increased morbidity, when compared to the more gradual
oral fJ blockade.
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The curves show increasing survival advantage over time consequent to
earlyTIMI grade 3, (compared with all lesser grades) between 30 days (arrow)
and 12 months. The one year mortality risk reduction for grade 3 flow is 54%
(again vs TIMI grades 0, 1, & 2 combined) p < 0.0001. Notably the total fatal-
ity rate from 30 days to one year in the grade 3 group was only 1.4%. Con-
clusion: The enlarging cumulative survival advantage associated with early
establishment of grade 3 flow has been shown (in a robust, prospectively
followed population) to be progressive at least through one full post MI year.
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Late Clinical and Echocardiographic Follow-up
After Left Ventricular Endoaneurysmorrhaphy
Demonstration of Blood Flow Through
Transmyocardial Laser Channels
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LCX without channels
LAD with channels
The numberof spheres in the channel region was significantly higher than
in the control region but did not vary with loading conditions. These data
provide direct evidence that blood from the LV can reach the myocardium
through TMR channels in the acute setting. Ouantification of the flow and
whether this can be maintained in the chronic setting are important ques-
tions for future research.
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ADULT CARDIOTHORACIC SURGERY
Transmyocardiallaser revascularization ITMR) is a new procedure under in-
vestigation for treatment of patients with myocardial ischemia who are unre-
sponsive to other conventional therapies. In theory, TMR channels passing
from the LV chamber directly into the myocardium allow oxygenated blood
to directly perfuse the myocardium, bypassing the coronary vessels. How-
ever, experimental evidence that blood actually flows through the channels
has not been available previously. Therefore, the purpose of this study was
to test whether blood can reach the myocardium by passing through laser
channels. An average of 28 channels/heart were made over the LAO dis-
tribution in 5 canine hearts using a pulsed holmiumlYAG laser 120 pulses,
0.6J/pulse) with energy delivered from the endocardium through a 400 IJ.
fiber optic cable introduced via the left atrial appendage. The heart was then
excised while coronary perfusion pressure was maintained constant at 120
mmHg by retrograde aortic blood flow provided by a second dog (aortic
valve always remains closed). The proXimal LAO and epicardial collaterals
were ligated. Collateral flow to the ischemic region, measured by colored
microspheres injected into the coronary artery, was 20.5% of normal (0.42
± 0.28 mllglmin vs. 2.05 ± 0.68 mllglmin in the non-ischemic region). Col-
ored spheres were then injected into blood placed within the LV chamber to
achieve peak LV pressure generation of 20 mmHg (low loading) and then 60
mmHg (high loading) (this blood is not ejected into the aorta). The number
of spheres detected per gram of myocardium in the circumflex ILCX) region
(control area without TMR channels) and in the LAO region with TMR chan-
nels are shown in the table as a function of LV loading:
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Infarct expansion and aneurysm (LVA) formation has a poor prognosis. Tra-
ditional techniques of LVA resection may be associated with suboptimal re-
sults, and do not fully restore LV geometry. LVendoaneurysmorrhaphy(LVEA)
is a newer operative technique which utilizes an endocardial patch to ex-
clude the aneurysm and normalize LV geometry. Late clinical and echocar-
diographic features of these patients (pts) is unknown. We prospectively fol-
lowed 51 consecutive pts who had undergone LVEA. Average duration of
follow-up (FlU) was 4.6 years (range 2-10 years). All pts had clinical evalua-
tion and review of medical records.
Results: There were 2 (4%) peri-operative deaths, 2 (4%) in-hospital
deaths, and 13 (24%) late deaths. Clinical improvement was noted in all 34
survivors:
NYHA Pre-op FlU CCS Pre-op FlU
Class (%) (%) Angina (%) (%)
I 5 (151 21 (62) I 12 (35) 29 (85)
II 9 (26) 8 (24) II 3 ( 9) 5 (15)
III 13 (38) 4 (12) III 5 (15) 0
IV 7 (21) 1 ( 3) IV 14 (41) 0
30 surviving pts had FlU 20 echocardiograms (20E). Near normal LV ge-
ometry was restored in all pts, and no patch aneurysms were noted at late
FlU. 24/30 20Es were adequate for quantitative analysis. The average LVEF
post-op was 40.2% using the modified biplane analysis.
Conclusions: LV endoaneurysmorrhaphy was associated with a 72% over-
all survival after average 4.6 year FlU. All survivors had improvement in clini-
cal status and normalization of LV geometry.
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One-Year Fallaw-up of Patients Treated with
Prolonged Low-dose of rt-PA for Refractory
Unstable Angina
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We have previously shown an in-hospital beneficial effect of prolonged
thrombolysis with rt-PA in patients with refractory unstable angina. The aim
of this study was to assess whether the short term effect of this therapy
is sustained after one year. The study population included 67 patients (pts)
with unstable angina refractory to common antianginal therapy. Thirty-six pts
(group A) were randomized to receive rt-PA (0.03 mglkglhour for 3 consec-
utive days) plus heparin (ACT 250--400 sec), and 31 pts to receive heparin
(ACT 250--400 sec) plus placebo infusion. Both groups also received con-
ventional therapy with nitrates, p-blockers and Calcium channel blockers.
One pt of group A and 4 of group B (3% vs 13%, P < 0.01) developed acute
myocardial infarction during hospitalisation. Eight pts of group B underwent
coronary artery surgery because of persistence of symptoms during hospi-
talization. Group B pts more frequently shown recurrent angina (8% vs 19%,
p < 0.05) and total ischemic burden >60 min/day on ambulatory ECG moni-
toring (8% vs 19%, p < 0.05). After a mean follow up of 14 ± 6 months 3 pts
from group A and 7 pts from group B suffered an acute myocardial infarc-
tion (9% vs 30%, P < 0.05). Seven patients died for cardiac related causes
(3 in group A and 4 in group B), 38 patients (20 in group A and 18 in group
S, 57% vs 78.3%) underwent PTCA or CABG. Eight pts from group A and 1
patient from group B (23% vs 4% P < 0.05) remained angina free on medical
therapy.
In conclusion, the benefits of prolonged low-dose of rt-PA for refractory
unstable angina persist for at least one year.
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OT dispersion (OT max minus OT min) is an important measure of arrhyth-
mia risk, providing information about heterogeneity of ventricular repolarisa-
tion. We studied aT dispersion for all cause mortality in patients from the
placebo arm of a large therapeutic intervention trial in acute myocardial in-
farction. Standard 12 lead electrocardiograms (ECGs) were analysed from
day 2 or 3 of the acute infarction; and if available, from a later period of life
(more than 1 month post infarct). The only exclusions were patients with
chronic atrial fibrillation or paced rhythm, or those with ECGs of too poor
quality to be analysed. The ECGs were scanned, and the image divided into
12 files corresponding to the 12 leads of the standard ECG. Specially de-
signed software then skeletonised and joined each file, which is then avail-
able for either user-interactive or automatic measurement of OT dispersion,
again using specially designed software. The following results are all user in-
teractive, and are rate and lead corrected (rate corrected aT max minus OT
min divided by the square root of the number of leads with a measureable
OT interval). For the group known to have deceased 163 patients had ECGs
analysed during the early stage of acute myocardial infarction, and 53 had
ECGs recorded later in life. 163 age and sex matched survivors in the same
study have been analysed, of these 82 have had ECGs recorded later in life.
Mean adjusted aT dispersion for the death group is 36.6 ms (SO 14.7), and
for survivors 35.2 ms (SO 13.9), poNS; for ECGs recorded on day 2 or 3 of
acute myocardial infarction. ECGs recorded later in life have an adjusted OT
dispersion of 31.2 ms (SO 13.9) for the deceased group, and for survivors of
24.5 ms (SO 9.5), P < 0.01. aT dispersion is prolonged in the early stages
of acute myocardial infarction, and for long term survivors then falls towards
more normal values. Conclusions: The failure of OT dispersion to normalise
in patients who subsequently decease is an important observation, and may
provide insight into the causes of mortality in this group.
